Antibiotics :Targets, Mechanisms and Resistance

Publication subTitle :Targets, Mechanisms and Resistance

Author: Claudio O. Gualerzi  

Publisher: John Wiley & Sons Inc‎

Publication year: 2013

E-ISBN: 9783527659715

P-ISBN(Hardback):  9783527333059

Subject: R978.1 Antibiotics

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Most of the antibiotics now in use have been discovered more or less by chance, and their mechanisms of action have only been elucidated after their discovery. To meet the medical need for next-generation antibiotics, a more rational approach to antibiotic development is clearly needed.

Opening with a general introduction about antimicrobial drugs, their targets and the problem of antibiotic resistance, this reference systematically covers currently known antibiotic classes, their molecular mechanisms and the targets on which they act. Novel targets such as cell signaling networks, riboswitches and bacterial chaperones are covered here, alongside the latest information on the molecular mechanisms of current blockbuster antibiotics.

With its broad overview of current and future antibacterial drug development, this unique reference is essential reading for anyone involved in the development and therapeutic application of novel antibiotics.

Chapter

Title Page

pp.:  1 – 5

Copyright

pp.:  5 – 6

Contents

pp.:  6 – 7

Preface

pp.:  7 – 19

List of Contributors

pp.:  19 – 21

Chapter 3 Impact of Microbial Natural Products on Antibacterial Drug Discovery

pp.:  49 – 79

Chapter 4 Antibiotics and Resistance: A Fatal Attraction

pp.:  79 – 99

Chapter 5 Fitness Costs of Antibiotic Resistance

pp.:  99 – 135

Chapter 6 Inhibitors of Cell-Wall Synthesis

pp.:  135 – 159

Chapter 7 Inhibitors of Bacterial Cell Partitioning

pp.:  159 – 177

Chapter 8 The Membrane as a Novel Target Site for Antibiotics to Kill Persisting Bacterial Pathogens

pp.:  177 – 209

Chapter 9 Bacterial Membrane, a Key for Controlling Drug Influx and Efflux

pp.:  209 – 243

Chapter 10 Interference with Bacterial Cell-to-Cell Chemical Signaling in Development of New Anti-Infectives

pp.:  243 – 267

Chapter 11 Recent Developments in Inhibitors of Bacterial Type IIA Topoisomerases

pp.:  267 – 289

Chapter 12 Antibiotics Targeting Bacterial RNA Polymerase

pp.:  289 – 325

Chapter 13 Inhibitors Targeting Riboswitches and Ribozymes

pp.:  325 – 349

Chapter 14 Targeting Ribonuclease P

pp.:  349 – 381

Chapter 15 Involvement of Ribosome Biogenesis in Antibiotic Function, Acquired Resistance, and Future Opportunities in Drug Discovery

pp.:  381 – 397

Chapter 16 Aminoacyl-tRNA Synthetase Inhibitors

pp.:  397 – 413

Chapter 17 Antibiotics Targeting Translation Initiation in Prokaryotes

pp.:  413 – 437

Chapter 18 Inhibitors of Bacterial Elongation Factor EF-Tu

pp.:  437 – 463

Chapter 19 Aminoglycoside Antibiotics: Structural Decoding of Inhibitors Targeting the Ribosomal Decoding A Site

pp.:  463 – 479

Chapter 20 Peptidyltransferase Inhibitors of the Bacterial Ribosome

pp.:  479 – 497

Chapter 21 Antibiotics Inhibiting the Translocation Step of Protein Elongation on the Ribosome

pp.:  497 – 517

Chapter 22 Antibiotics at the Ribosomal Exit Tunnel-Selected Structural Aspects

pp.:  517 – 535

Chapter 23 Targeting HSP70 to Fight Cancer and Bad Bugs: One and the Same Battle?

pp.:  535 – 551

Index

pp.:  551 – 565

LastPages

pp.:  565 – 575

The users who browse this book also browse


No browse record.